Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Cash from Operations (2016)

Microbot Medical's Cash from Operations history spans 7 years, with the latest figure at 19000.0 for Q4 2016.

  • For the quarter ending Q4 2016, Cash from Operations fell 100.08% year-over-year to 19000.0, compared with a TTM value of 786000.0 through Dec 2016, down 2.75%, and an annual FY2025 reading of 13046000.0, down 47.8% over the prior year.
  • Cash from Operations for Q4 2016 was 19000.0 at Microbot Medical, up from 421000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 22985255.0 in Q4 2015, with the low at 8907215.0 in Q1 2015.
  • Average Cash from Operations over 5 years is 3604738.8, with a median of 5816385.5 recorded in 2012.
  • Year-over-year, Cash from Operations tumbled 105.65% in 2014 and then surged 459.6% in 2015.
  • Tracing MBOT's Cash from Operations over 5 years: stood at 4919534.0 in 2012, then plummeted by 40.05% to 6889821.0 in 2013, then increased by 7.23% to 6391855.0 in 2014, then surged by 459.6% to 22985255.0 in 2015, then plummeted by 100.08% to 19000.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Cash from Operations are 19000.0 (Q4 2016), 421000.0 (Q3 2016), and 53000.0 (Q2 2016).